A new Colorado bill is drawing attention across the aesthetics and longevity industry. Colorado Senate Bill 26-130, titled the “Medical Spa Prescription Drug Consumer Protection Act,” proposes to significantly expand oversight of medical spas that administer prescription drugs.
If enacted, the legislation would not create an entirely new licensing structure for med spas. Instead, it would take a different approach: using consumer protection law to regulate how medical spas acquire, store, market, and administer prescription medications.
For clinic operators, this distinction matters.
What the Bill Actually Does
SB 26-130 would classify certain medical spa practices involving prescription drugs as “unfair or deceptive trade practices” under the Colorado Consumer Protection Act.
That means violations could be enforced by the Colorado Attorney General or local district attorneys, rather than solely by professional licensing boards.
The bill applies broadly to facilities that offer cosmetic, aesthetic, wellness, longevity, or lifestyle treatments involving prescription medications such as injectables, hormones, or IV therapies.
In other words, this legislation squarely targets the modern med spa and longevity clinic business model.
The Key Practices the Bill Would Prohibit
Under the proposed law, medical spas would violate consumer protection rules if they engage in certain conduct involving prescription drugs.
These include:
1. Improper Drug Sourcing
A medical spa could not acquire prescription drugs from anyone not legally authorized to distribute them.
This provision targets gray-market sourcing and questionable supply chains.
2. Improper Drug Handling or Administration
Facilities must store, handle, prepare, and administer prescription drugs in accordance with:
- Manufacturer instructions
- Federal and state law
- Accepted medical standards
This creates a direct statutory hook for enforcement if practices cut corners on drug handling.
3. Practicing Outside Scope of Credentials
The bill would prohibit allowing any individual to prescribe or administer prescription drugs outside the scope of their professional license.
This reinforces existing scope-of-practice rules but places them under consumer protection enforcement.
4. Misleading Drug Claims
The bill specifically targets marketing and representation of prescription drugs.
A medical spa may not represent that a drug:
- Is FDA-approved when it is not
- Has benefits it does not actually have
- Is safe or effective in ways inconsistent with FDA labeling
This provision could affect how clinics market:
- peptide therapies
- compounded medications
- weight-loss treatments
- longevity therapies
5. Failure to Maintain Clinical Oversight
Medical spas must designate a licensed healthcare provider with prescriptive authority to oversee prescription drug use within the facility.
This reinforces the importance of medical direction in aesthetics practices.
6. Failure to Track Serious Adverse Events
The bill also requires med spas to create and maintain records of serious adverse events involving prescription drugs and produce them if requested by regulators.
Serious adverse events include outcomes such as hospitalization, life-threatening reactions, disability, or death.
Why Lawmakers Say the Bill Is Necessary
The legislation’s findings state that medical spas increasingly administer prescription drugs in settings marketed primarily for cosmetic, aesthetic, wellness, or lifestyle treatments, where regulatory oversight can vary depending on the practice structure and provider credentials.
Lawmakers argue that inconsistent standards create a risk of patient harm, particularly when drugs are used without proper medical oversight or outside a practitioner’s scope of practice.
Rather than creating a new regulatory agency or licensing scheme, the bill attempts to strengthen enforcement using existing consumer protection laws.
The Strategic Shift: Consumer Protection Enforcement
This is the most significant aspect of SB 26-130.
Traditionally, medical spa compliance has been enforced through:
- medical boards
- nursing boards
- pharmacy boards
This bill adds a powerful new layer: consumer protection enforcement.
That means investigations could be initiated by:
- the state attorney general
- local district attorneys
These agencies typically have broader investigative powers and civil enforcement authority.
What Med Spa Owners Should Be Thinking About Now
Although the bill is still under consideration in the Colorado legislature, it signals a broader regulatory trend.
States are increasingly focusing on how prescription drugs are used in aesthetic and wellness settings.
Practices should review:
- drug sourcing policies
- storage and handling procedures
- marketing language around medications
- scope-of-practice compliance
- documentation of adverse events
- medical director oversight structures
Even if this specific bill changes before passage, the direction of regulation is clear.
The Bigger Picture for the Aesthetics Industry
Colorado’s proposal reflects a national shift in how regulators view medical spas.
Rather than regulating procedures themselves, lawmakers are increasingly focusing on prescription drugs used in aesthetic medicine, including:
- botulinum toxins
- dermal fillers
- IV therapies
- hormone treatments
- weight-loss medications
- peptide and longevity therapies
For clinic operators, the message is simple: drug compliance is becoming the central regulatory issue in the med spa industry.